MarketsStocksCONCORDBIO
CO

Concord Biotech Ltd

NSE: CONCORDBIOBSE: 543960Healthcare
Download Research Report7-page PDF
1,193.90
-1.32%
NSE · auto-updates while market open
Prev Close
₹1,926.60
Day High
₹1,230.90
Day Low
₹1,190.00
Mkt Cap
₹12,434 Cr
P / E
48.0
P / B
6.2
ROE
13.5%
52W High
₹2,150.40
52W Low
₹987.00
Key Metrics
Market Cap
₹12,434 Cr
P / E
47.97
P / B
6.17
EV / EBITDA
34.72
ROCE
27.4%
ROE
13.5%
Debt / Equity
0.00
Book Value
₹192.81
EPS
₹24.78
Div Yield
0.9%
Face Value
₹1
Promoter Holding
44.1%
Revenue · ₹ Cr
1.0k
FY24
1.2k
FY25
1.1k
FY26
Net Profit · ₹ Cr
308
FY24
372
FY25
259
FY26
EPS · ₹ per share
₹29.4
FY24
₹35.5
FY25
₹24.8
FY26
P / E Ratio · price ÷ TTM EPS
2950719241190-3Apr 24Dec 24Sept 25Jun 26
P/E 48.3×Median 51.0×TTM EPS
Q1 2026 snapshot
Sales
₹341 Cr
Operating profit
-
OPM
-
Net profit
₹88 Cr
EPS
₹8.46
Scorecard · 7 axes
Quality
Strong
82/100
Valuation
Weak
48.0×
Growth
Good
+15.1%
Profitability
Strong
20.5%
Performance
Bad
-34.6%
Entry Point
Strong
56%
Red Flags
Strong
0 flags
Shareholding Pattern
44.1%Promoter
Promoter44.1%
FII7.8%
DII9.2%
Public38.9%
Quarterly Results · ₹ Cr
QuarterFY24 12QFY25 03QFY25 06QFY25 09QFY25 12QFY26 03Q
Revenue244.22439.27217.67260.41287.74341.43
Net Profit75.921140.38744.05863.06363.64288.467
NPM %31.1%32.0%20.2%24.2%22.1%25.9%
AlertPre-trade